Coverage
— → Added to coverage
Current stock research snapshot · Not reviewed Date unavailable
TMDXTransMedics
Investment conviction●●●○○3 of 5 · current snapshot
Research target—Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap$3.07BSnapshot value · Not reviewed
Research history
See all TMDX changes ↗What changed
Organ Care System (OCS) — ex-vivo perfusion + national organ logistics network. Razor-blade (console + single-use perfusion set per organ) with network effects from coordinating retrieval/transport. Expands usable donor-organ pool. Closest toll-road-like asset in the organ-replacement wave; recurring disposable + logistics moat.
Lung/heart/liver OCS volume growth; national logistics network expansion; transplant-center workflow lock-in; organ-shortage demand (~100k+ US waiting list).
Reimbursement cuts; hospital consolidation; aviation/logistics cost overruns; perfusion competition; slower organ-volume growth.
No social-sentiment snapshot available.
Snapshot · Not reviewed🟢 Lean-Bull · ins-$3.1M · 13F 18+/4-×0.5 · short↓0.29
Snapshot · Not reviewed